drugset
drugset / Trial / NCT04958135

Study to Assess the Effect of Food on a Single Dose of Acoramidis in Healthy Adult Participants

NCT04958135 ↗

Phase 1 Completed 18 enrolled Alexion Pharmaceuticals, Inc. Celerion · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine the effect of a high-fat, high-caloric meal on the pharmacokinetics (PK) of acoramidis in healthy adult participants following an oral single dose administration of acoramidis. Blood sampling for PK assessment will include measures for acoramidis and its metabolite, acoramidis acyl glucuronide (acoramidis-AG).

Timeline

Start
2021-05-30
Primary completion
2021-08-04
Completion
2021-08-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Acoramidis Unknown — Oral

Indications

No indication recorded.